
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Oncology
Study Phase : Undisclosed
Recipient : Edward Messing
Deal Size : Inapplicable
Deal Type : Inapplicable
Near Infrared Fluorescence Imaging for Bladder Cancer Detection
Details : Hexaminolevulinate HCl is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Urinary Bladder Neoplasms.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 23, 2017
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Recipient : Edward Messing
Deal Size : Inapplicable
Deal Type : Inapplicable
